Cite
HARVARD Citation
Ding, C. et al. (2018). LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma. Journal of cellular biochemistry. 119 (12), pp. 10406-10414. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ding, C. et al. (2018). LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma. Journal of cellular biochemistry. 119 (12), pp. 10406-10414. [Online].